Citadel Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-158,012
| Closed | -$50M | – | 7034 |
|
|
2023
Q4 | $50M | Sell |
158,012
-31,585
| -17% | -$10M | 0.01% | 469 |
|
|
2023
Q3 | $32.1M | Buy |
189,597
+94,863
| +100% | +$16M | 0.01% | 600 |
|
|
2023
Q2 | $20.5M | Buy |
+94,734
| New | +$20.5M | ﹤0.01% | 804 |
|
|
2023
Q1 | – | Sell |
-28,168
| Closed | -$5.54M | – | 6791 |
|
|
2022
Q4 | $5.54M | Sell |
28,168
-55,673
| -66% | -$10.9M | ﹤0.01% | 1696 |
|
|
2022
Q3 | $18.9M | Buy |
83,841
+64,222
| +327% | +$14.4M | ﹤0.01% | 860 |
|
|
2022
Q2 | $2.48M | Buy |
19,619
+2,931
| +18% | +$371K | ﹤0.01% | 2538 |
|
|
2022
Q1 | $2.12M | Buy |
16,688
+9,313
| +126% | +$1.18M | ﹤0.01% | 2951 |
|
|
2021
Q4 | $966K | Sell |
7,375
-4,066
| -36% | -$533K | ﹤0.01% | 3887 |
|
|
2021
Q3 | $1.4M | Buy |
11,441
+9,629
| +531% | +$1.18M | ﹤0.01% | 3411 |
|
|
2021
Q2 | $207K | Buy |
+1,812
| New | +$207K | ﹤0.01% | 5548 |
|
|
2021
Q1 | – | Sell |
-26,236
| Closed | -$2.67M | – | 6946 |
|
|
2020
Q4 | $2.67M | Buy |
26,236
+17,226
| +191% | +$1.75M | ﹤0.01% | 2296 |
|
|
2020
Q3 | $696K | Buy |
9,010
+1,595
| +22% | +$123K | ﹤0.01% | 3217 |
|
|
2020
Q2 | $826K | Sell |
7,415
-76,336
| -91% | -$8.5M | ﹤0.01% | 3027 |
|
|
2020
Q1 | $6.03M | Buy |
83,751
+79,099
| +1,700% | +$5.7M | ﹤0.01% | 1324 |
|
|
2019
Q4 | $351K | Sell |
4,652
-73,721
| -94% | -$5.56M | ﹤0.01% | 3766 |
|
|
2019
Q3 | $1.28M | Sell |
78,373
-47,625
| -38% | -$777K | ﹤0.01% | 2724 |
|
|
2019
Q2 | $2.52M | Buy |
+125,998
| New | +$2.52M | ﹤0.01% | 2234 |
|